Your session is about to expire
← Back to Search
Procedure
Enhanced Point of Care Ultrasound for COPD (ACCUMEN-POCUS Trial)
N/A
Recruiting
Led By Michelle Grinman, MD FRCPC MPH
Research Sponsored by Michelle Grinman
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Diagnosis of CHF and/or COPD that requires HH care
No painful/broken ribs that could be affected by pressure applied when performing lung POCUS
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the date of admission to discharge from the index admission, assessed up to 1 year
Awards & highlights
ACCUMEN-POCUS Trial Summary
This trial compares ultrasounds with standard care to improve patient experience, save costs and test feasibility of home-based acute care using non-physicians.
Who is the study for?
This trial is for adults over 18 with Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF), who need home health care but are stable enough not to require more than two visits per day. They must be able to follow a management plan, have no allergies to ultrasound gel, and no new unstable rib fractures.Check my eligibility
What is being tested?
The study compares the use of an enhanced daily lung assessment tool called POCUS-PRESUNA against standard home-based acute care in patients with COPD/CHF. It aims to see if this technology can improve patient and provider experiences, reduce healthcare costs, and test its feasibility for long-term use by non-physicians at home.See study design
What are the potential side effects?
Since the intervention involves non-invasive ultrasound assessments, side effects are minimal but may include discomfort from pressure during the procedure if there are existing painful conditions like broken ribs.
ACCUMEN-POCUS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have CHF or COPD and need home health care.
Select...
I don't have painful or broken ribs that could be hurt by pressure during a lung ultrasound.
Select...
I am 18 years old or older.
ACCUMEN-POCUS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from the date of admission to discharge from the index admission, assessed up to 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the date of admission to discharge from the index admission, assessed up to 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Length of stay
Secondary outcome measures
Cost analysis
Health Related Quality of Life - EuroQuol- 5-Dimension-5-Level (EQ-5D-5L) -Activities of daily living
Health Related Quality of Life - EuroQuol- 5-Dimension-5-Level (EQ-5D-5L) -Anxiety and Depression
+17 moreACCUMEN-POCUS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: POCUS-PRESUNAExperimental Treatment2 Interventions
Daily home hospital care will be enhanced by lung POCUS acquired remotely by community paramedics or in-person by physicians, and interpreted by physicians. They will then document their findings on PRESUNA to obtain a longitudinal record that enables monitoring of trends to support clinical decision-making.
Group II: Standard CareActive Control1 Intervention
Standard home hospital care
Find a Location
Who is running the clinical trial?
Alberta Boehringer Ingelheim CollaborationUNKNOWN
1 Previous Clinical Trials
60 Total Patients Enrolled
Michelle GrinmanLead Sponsor
PRESUNAUNKNOWN
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this trial actively seeking participants?
"Affirmative. Information displayed on clinicaltrials.gov suggests that this health study is still enrolling patients, with 44 required for the single site it originated from (10/16/2023). It was last edited 11/29/2023."
Answered by AI
How many individuals have signed up for participation in this medical exploration?
"Affirmative. According to the clinicaltrials.gov website, enlistment for this medical study is still open and ongoing; it was announced on October 16th 2023 with a most recent update on November 29th of that same year. 44 volunteers are needed from one site in total."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger